Milrinone or Dobutamine for Cardiogenic Shock?

September 27, 2021 00:25:40
Milrinone or Dobutamine for Cardiogenic Shock?
Critical Care Perspectives in Emergency Medicine
Milrinone or Dobutamine for Cardiogenic Shock?

Sep 27 2021 | 00:25:40

/

Show Notes

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.  Which agent was the winner?

You can get CME credit for this episode hereClick here for CME Account Creation Instructions

Other Episodes

Episode 0

October 04, 2022 00:25:21
Episode Cover

Does a Restrictive Oxygenation Target Make a Difference in the Post-Arrest Patient?

The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require...

Listen

Episode 0

July 21, 2019 00:19:47
Episode Cover

Critically Ill Patients with Vibrio Infection

With increasing water temperatures, there is a rise in the incidence of V.vulnificus infections in non-endemic regions.  Patients with V.vulnificus infection are often critically...

Listen

Episode 0

July 01, 2021 00:26:54
Episode Cover

The TTM2 Trial

Current international guidelines recommend TTM for adult patients with ROSC from OHCA who remain comatose or unable to follow verbal commands.  However, the overall...

Listen